203 related articles for article (PubMed ID: 12970422)
1. Early transcription from nonintegrated DNA in human immunodeficiency virus infection.
Wu Y; Marsh JW
J Virol; 2003 Oct; 77(19):10376-82. PubMed ID: 12970422
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro.
Spina CA; Guatelli JC; Richman DD
J Virol; 1995 May; 69(5):2977-88. PubMed ID: 7707524
[TBL] [Abstract][Full Text] [Related]
3. Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA.
Wu Y; Marsh JW
Science; 2001 Aug; 293(5534):1503-6. PubMed ID: 11520990
[TBL] [Abstract][Full Text] [Related]
4. CD8(+) cell noncytotoxic anti-human immunodeficiency virus response inhibits expression of viral RNA but not reverse transcription or provirus integration.
Mackewicz CE; Patterson BK; Lee SA; Levy JA
J Gen Virol; 2000 May; 81(Pt 5):1261-4. PubMed ID: 10769068
[TBL] [Abstract][Full Text] [Related]
5. Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells.
Lassen KG; Ramyar KX; Bailey JR; Zhou Y; Siliciano RF
PLoS Pathog; 2006 Jul; 2(7):e68. PubMed ID: 16839202
[TBL] [Abstract][Full Text] [Related]
6. The RNA helicase DDX1 is involved in restricted HIV-1 Rev function in human astrocytes.
Fang J; Acheampong E; Dave R; Wang F; Mukhtar M; Pomerantz RJ
Virology; 2005 Jun; 336(2):299-307. PubMed ID: 15892970
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells.
Zhou Y; Zhang H; Siliciano JD; Siliciano RF
J Virol; 2005 Feb; 79(4):2199-210. PubMed ID: 15681422
[TBL] [Abstract][Full Text] [Related]
8. Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene.
zur Megede J; Chen MC; Doe B; Schaefer M; Greer CE; Selby M; Otten GR; Barnett SW
J Virol; 2000 Mar; 74(6):2628-35. PubMed ID: 10684277
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection.
Pierson TC; Zhou Y; Kieffer TL; Ruff CT; Buck C; Siliciano RF
J Virol; 2002 Sep; 76(17):8518-31. PubMed ID: 12163571
[TBL] [Abstract][Full Text] [Related]
10. CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.
Le Borgne S; Février M; Callebaut C; Lee SP; Rivière Y
J Virol; 2000 May; 74(10):4456-64. PubMed ID: 10775581
[TBL] [Abstract][Full Text] [Related]
11. Molecular and virological effects of intracellular anti-Rev single-chain variable fragments on the expression of various human immunodeficiency virus-1 strains.
Duan L; Zhang H; Oakes JW; Bagasra O; Pomerantz RJ
Hum Gene Ther; 1994 Nov; 5(11):1315-24. PubMed ID: 7893803
[TBL] [Abstract][Full Text] [Related]
12. Vpr is required for efficient Nef expression from unintegrated human immunodeficiency virus type 1 DNA.
Poon B; Chang MA; Chen IS
J Virol; 2007 Oct; 81(19):10515-23. PubMed ID: 17652391
[TBL] [Abstract][Full Text] [Related]
13. Early molecular replication of human immunodeficiency virus type 1 in cultured-blood-derived T helper dendritic cells.
Langhoff E; Kalland KH; Haseltine WA
J Clin Invest; 1993 Jun; 91(6):2721-6. PubMed ID: 8514880
[TBL] [Abstract][Full Text] [Related]
14. Induction of secreted human immunodeficiency virus type 1 (HIV-1) resistance factors in CD4-positive T lymphocytes by attenuated HIV-1 infection.
Simm M; Miller LS; Durkin HG; Allen M; Chao W; Lesner A; Potash MJ; Volsky DJ
Virology; 2002 Mar; 294(1):1-12. PubMed ID: 11886260
[TBL] [Abstract][Full Text] [Related]
15. Controlling elements in replication of the human immunodeficiency virus type 1.
Li X; Quan Y; Wainberg MA
Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):443-54. PubMed ID: 9193800
[TBL] [Abstract][Full Text] [Related]
16. Regulation of expression of human immunodeficiency virus.
Pavlakis GN; Felber BK
New Biol; 1990 Jan; 2(1):20-31. PubMed ID: 2078551
[TBL] [Abstract][Full Text] [Related]
17. Novel regulation of HIV-1 replication and pathogenicity: Rev inhibition of integration.
Levin A; Hayouka Z; Brack-Werner R; Volsky DJ; Friedler A; Loyter A
Protein Eng Des Sel; 2009 Dec; 22(12):753-63. PubMed ID: 19875511
[TBL] [Abstract][Full Text] [Related]
18. Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients.
Woffendin C; Ranga U; Yang Z; Xu L; Nabel GJ
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2889-94. PubMed ID: 8610137
[TBL] [Abstract][Full Text] [Related]
19. Analysis of trans-dominant mutants of the HIV type 1 Rev protein for their ability to inhibit Rev function, HIV type 1 replication, and their use as anti-HIV gene therapeutics.
Ragheb JA; Bressler P; Daucher M; Chiang L; Chuah MK; VandenDriessche T; Morgan RA
AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1343-53. PubMed ID: 8573391
[TBL] [Abstract][Full Text] [Related]
20. Protection of primary human T cells from HIV infection by Trev: a transdominant fusion gene.
Chinen J; Aguilar-Cordova E; Ng-Tang D; Lewis DE; Belmont JW
Hum Gene Ther; 1997 May; 8(7):861-8. PubMed ID: 9143912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
